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Reversible Supramolecular System of Porphyrin Exchange 
between Inclusion in Cyclodextrin and Intercalation in DNA by 
Change in pH 
Shota Notsu, Kouta Sugikawa, and Atsushi Ikeda* 
 
Abstract: Under the coexistence of cyclodextrin and DNA in water, 
5,10,15,20-tetra(4-pyridyl)porphyrin interacted with the cavities of two 
cyclodextrin molecules in a solution at an around neutral pH and 
intercalated into DNA under acidic conditions. The supramolecular 
phenomena occurred completely and reversibly owing to the change 
in pH. 
Porphyrins have been widely used in biological applications, 
such as inhibitors of human telomerases,[1] photosensitizers 
for photodynamic therapy,[2,3] DNA photocleaving agents,[4] 
and as a specific probe of DNA structure.[5] To fulfil these 
important functions porphyrins need to bind strongly with 
their target biomolecules. Furthermore, the ability to control 
the amount of porphyrins bound to biomolecules by using 
external stimuli would be beneficial. Several of these 
applications involve the interaction of porphyrins with DNA. 
Three major DNA binding modes have been proposed for the 
interaction of cationic porphyrins to DNA: (i) intercalation; (ii) 
outside groove binding; and (iii) outside binding with self-
stacking in which porphyrins stack along the DNA helix.[6] We 
have previously demonstrated the exchange of porphyrins 
between cyclodextrins[7,8] and liposomes.[9] Other guest 
molecules, such as azobenzene,[10] stilbene,[10] and 
fullerenes[11] are released from the cavity of cyclodextrin and 
transfer into liposomal membranes. In this report, we 
demonstrated that 5,10,15,20-tetra(4-pyridyl)porphyrin (1) 
complexed with trimethyl-β-cyclodextrin (TMe-β-CDx; Figure 
1) was reversibly transferred to DNA by a pH-dependent 
switch. 
 The 1•TMe-β-CDx complex was prepared using a 
mechanochemical high-speed-vibration milling apparatus. 
[3,7] The UV-vis spectrum of the complex showed an 
absorption maximum (λmax) at 414 nm in water, 
corresponding to the Soret band of the porphyrin, as well as 
several other bands at 509, 541, 584, and 640 nm, which 
were attributed to the Q bands of the porphyrin (Figure 2a, 
red line). We have already reported that the 1•TMe-β-CDx 
complex had 1:2 stoichiometry and there were two kinds of  
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Figure 1. Compound structures and schematic illustration of the 1•TMe-β-CDx 
complex. 
 
Scheme 1. Schematic illustration of the porphyrin-exchange reaction between 
a) cyclodextrins and b) DNA by a change in pH. 
pyridyl moieties (Figure 3b):[3] two of the pyridyl moieties 
penetrated the upper rim of each TMe-β-CDx (A in Scheme 
1a) and the other two were sandwiched by two TMe-β-CDxs 
(B in Scheme 1a). We attempted to determine the 
association constant (Kass) of the 1•TMe-β-CDx complex at 
pH 8.3, but failed because the absorption change gave a 
straight line in the titration (Figure S1). This is because the 
concentration of 1 was low and free 1 formed self-aggregates 
owing to its low solubility in water under neutral pH conditions. 
Therefore, the Kass value was determined under acidic 
conditions (pH 2.1). A plot of the proportion of 1 versus [TMe-
β-CDx] gave a sigmoidal curve,[12] which indicated that the 
inclusion of 1 in two TMe-β-CDxs occurred according to a 
well-defined cooperative phenomenon (Figure S2a). The 
TMe-β-CDx-binding profile of this complex was analysed 
using the Hill equation: log[y/(1 – y)] = n log[TMe-β-CDx] – 
log Kass, in which Kass and n are the association constant and 
Hill coefficients, respectively, and y = Kass/([1] – n – Kass).[13] 
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From the slope and the intercept of the linear plot in the range 
of [TMe-β-CDx] = 0.5–5.2 mM, we obtained a Kass value of 
380 for the 1•TMe-β-CDx complex (correlation coefficient 
0.990), together with an n value of 1.4 (Figure S2b). Although 
the details for the cooperative phenomenon are not clear at 
present, it was considered that a steric hindrance of inclusion 
in one TMe-β-CDx inhibited the rotation of the two pyridyl 
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Figure 2. UV-vis absorption spectra of a) DNA (black line), the 1•TMe-β-CDx 
complex before mixing with DNA (red line) and the 1•TMe-β-CDx complex after 
mixing with DNA (pH 2.8, blue line), after adding NaOH (pH 7.0, green line), 
after adding HCl (pH 2.8, orange line) and after adding NaOH (pH 6.8, purple 
line). Inset:•λmax of the Soret band versus pH change. b) UV-vis absorption 
spectra of the mixture of the 1•TMe-β-CDx complex and DNA at pH 7.1, 6.0, 5.2, 
4.0, 3.1, and 2.1. Inset: absorbance of the Soret band versus pH at 414 (black 
circles) and 431 (red circles) nm. c) The 1•TMe-β-CDx complex (pH 6.9, black 
line) and after adding HCl (pH 2.3, red line). 
moieties (A in Scheme 1a) and second inclusion of another 
TMe-β-CDx was accelerated because the loss of the Gibbs 
energy decreased (Scheme S1). 
 The absorption maximum shifted to 431 nm after mixing 
the complex with salmon sperm DNA in aqueous solution at 
30 °C (Figure 2a, blue line). Because the shift of the Soret 
band of 5,10,15,20-tetra(N-methylpyridinium-4-yl)porphyrin 
(TMPyP) has been shown to represent intercalation of 
TMPyP into DNA (436 nm)[14] the observed Soret shift 
indicated that 1 also intercalated into DNA. The pH of the 
mixture was 2.7 because the DNA solution used in this paper 
was acidic and a buffer was not used. We investigated the 
pH dependence of the UV-vis absorption spectra of the 
mixture of the 1•TMe-β-CDx complex and DNA (Figure 2b). 
Based on the pH titration, 1 was gradually protonated and 
intercalated in DNA at a pH below 5 (Figure 2b inset). To 
confirm the possibility of protonation of a pyrrole moiety in 1 
under acidic conditions, the UV-vis spectrum of the 1•TMe-
β-CDx complex was measured at pH 2.3 by the addition of 
HCl in H2O in the absence of DNA. The spectrum of the 
1•TMe-β-CDx complex at pH 2.3 showed very minor 
changes from that at pH 7 (Figure 2c), indicating that the 
pyrrole moiety in 1 was not protonated. Consequently, the 
result clearly shows that the pKb of the pyrrole moiety in 1 
was < pH 2.1. This result is consistent with the report that the 
pKb of a pyrrole moiety in 5,10,15,20-tetrakis(N-
methylpyridinium-4-yl)porphyrin is 1.4.[15]  
 To remove the influence of pH, the UV-vis spectrum was 
measured in a 0.2 M phosphate buffer solution (pH 6.8) 
containing the 1•TMe-β-CDx complex and DNA. The result 
showed that no spectral change was observed (Figure S3). 
In the 1H NMR spectrum, the peaks assigned to the 1•TMe-
β-CDx complex remained unchanged after mixing with DNA 
at pH 7.0 (Figure 3c). The result indicated that 1 did not 
transfer from two TMe-β-CDx cavities (Figure 1) to DNA 
under neutral pH conditions. Therefore, we anticipated that 1 
should return to the cavities of the two TMe-β-CDxs after 
changing from acidic conditions to neutral pH conditions. 
After returning the solution to neutral pH conditions by the 
addition of NaOH in H2O (pH 6.8), the absorption spectrum 
reverted to a spectrum that was similar to that recorded for 
the 1•TMe-β-CDx complex (Figure 2a, green line). The 
spectral changes were repeatedly reversible by the addition 
of HCl or NaOH in H2O (Figure 2a inset). The both exchange 
rates at pH 2.8 and 6.8 were very fast because the solution 
color changed immediately between blown and purple by pH 
changes. 
 1H NMR spectra (Figures 3 and S4-S8) were obtained to 
confirm if all of the porphyrins were released from the two 
TMe-β-CDx cavities after mixing DNA in D2O at 30 °C for 1 
h. In the absence of DNA, the peaks corresponding to the 
1•TMe-β-CDx complex in the NMR spectrum were observed 
(red and blue circles in Figure 3b and Figure S5a). In contrast, 
no peaks could be assigned to the 1•TMe-β-CDx complex 
following the addition of DNA (Figures 3c and S6). These 
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results clearly indicated that 1 was released completely from 
the TMe-β-CDx cavities. Particular peaks belonging to 1 
could have broadened, such as the peak at 8.9 ppm, and/or 
overlapped with the peaks arising from DNA. Peak 
broadening suggested that the molecular motions of 1 were 
suppressed by intercalation into DNA because of the 
formation of a high molecular weight species or a self-
aggregation process. Furthermore, the peaks corresponding 
to the 1•TMe-β-CDx complex reappeared after returning to 
neutral pD conditions following the addition of NaOD in D2O 
(pD 6.8)[16] (red and blue circles in Figure 3d and Figure S7). 
The result clearly showed that 1 re-interacts with two TMe-β-
CDx cavities (Scheme 1). The peaks corresponding to the 
1•TMe-β-CDx complex were present in the 0.2 M phosphate 
buffer solution (pD 6.8) (red and blue circles in Figure 3e and 
Figure S8), which showed that 1 was scarcely released from 
the two TMe-β-CDx cavities under neutral pD conditions. 
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Figure 3. Partial 1H NMR spectra of a) DNA, b‒d) the 1•TMe-β-CDx complex b) 
before and c and d) after mixing with c) DNA at 30 °C for 1 h (pD 2.7) and d) 
after the addition of NaOD in D2O (pD 6.8) and e) the 1•TMe-β-CDx complex 
after mixing with DNA at 30 °C for 1 h in 0.2 M a phosphate buffer solution (pD 
6.8) {[1] = 0.25 mM, [TMe-β-CDx] = 4.49 mM and [base pair of DNA] = 32.5 mM}. 
(●: free TMe-β-CDx, ●: TMe-β-CDx in the 1•TMe-β-CDx complex, and ●: 1 in 
the 1•TMe-β-CDx complex). 
 The intercalation of 1 into DNA can be confirmed by 
inhibiting the intercalation of ethidium bromide (EB) into DNA. EB 
has a strong fluorescence intensity upon intercalation into DNA.[17] 
Therefore, the inhibition of the intercalation of EB into DNA by 
other intercalators should lead to a decrease in the fluorescence 
intensity arising from the intercalation of EB into DNA.[15] As 
shown in Figure 4a, the fluorescence intensity of EB in the mixture 
of EB and DNA (black line) decreased upon addition of the 1•TMe-
β-CDx complex under acidic conditions (pH 2.8) (red line), 
suggesting that 1 intercalates partly into DNA (Scheme 1). In 
contrast, when 1 was scarcely released from the two TMe-β-CDx 
cavities in a 0.2 M phosphate buffer solution (pH 6.8), the 
fluorescence intensity of EB also barely changed (Figure 4b). 
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Figure 4. Fluorescence spectra of EB with DNA (black line), with a mixture of 
DNA and 1•TMe-β-CDx complex (red line) and without DNA (orange line), DNA 
only (green line) and the 1•TMe-β-CDx complex before and after mixing with 
DNA (purple and blue lines, respectively) under a) acidic conditions (pH 2.8) 
and b) neutral conditions [a 0.2 M phosphate buffer solution (pH 6.8)]. 
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Figure 5. CD spectra of the 1•TMe-β-CDx complex before (black line) and after 
mixing with DNA at 30 °C for 1 h (pH 2.7, red line) (1 mm cell, 25 °C). The inset 
shows the 380–460 nm region. 
 Under acidic conditions, there is a possibility that cationic 
1 dissolves in water alone after it is released from the cavities 
of CDxs. Circular dichroism (CD) spectra were recorded in 
an aqueous solution to confirm the intercalation of 1 into 
chiral DNA. Before mixing with DNA, 1 gave an induced CD 
(ICD) at 414 nm owing to the chiral TMe-β-CDx (Figure 5 
black line). After mixing with DNA, although the λmax shifted 
from 414 to 434 nm, the ICD of 1 remained despite the 
release of the chiral TMe-β-CDxs from the cavities (Figure 5 
red line). We investigated the pH dependence of the CD 
spectra of the mixture of the 1•TMe-β-CDx complex and DNA 
by the addition of NaOH in H2O (Figure S9). Based on the 
pH titration, the ICD at 434 decreased and the ICD at 414 nm 
increased with a rise in pH (Figure S9 inset). The CD 
spectrum at pH 7.1 (Figure S9 inset, black line) was similar 
to that of 1•TMe-β-CDx complex (Figure 5 inset, black line). 
These ICD spectra were not observed in a DNA solution in 
the absence of 1 (Figure S10). The result indicated that 1 still 
existed in the asymmetric field, i.e., 1 intercalated into the 
chiral DNA (Scheme 1). 
 In the absence of DNA, the 1H NMR spectrum of the 
1•TMe-β-CDx complex gave sharp peaks, which were 
assigned to free 1. We assumed that compound 1 was 
released from TMe-β-CDx at pH 1.0 because the spectrum 
was the same as that of pure 1 at pH 1.0 (Figure S5c and d). 
The peak broadening of 1 at pH 2.0 in the presence of DNA 
indicated that there was an equilibrium between the complex 
and free 1 (Figure S5b). These results clearly showed that 
the 1•TMe-β-CDx complex was unstable under acidic 
conditions because peak broadening was caused by 
coalescence between the free and complex states at pH 2.0 
and dissociated because no peaks could be assigned to 
TMe-β-CDx in the 1•TMe-β-CDx complex, whereas at pH 1.0 
the peaks could be assigned to free 1. The reason for the 
decomposition of the complex was an increase in the 
hydrophobicity and the generation of cations by protonation 
of the 4-pyridyl moieties of 1. Cationic porphyrins are known 
to form unstable complexes with TMe-β-CDx,[8] but the 
spontaneous aggregation of 1 under acidic conditions had 
not been considered. Furthermore, protonated 1 can interact 
through electrostatic interactions, as observed for the 
interaction between TMPyP and DNA.[14] Here, the 
protonation of 1 led to the destabilisation of the reactant and 
the stabilisation of the product. Both factors promoted the 
reaction. 
 In summary, compound 1 in the 1•TMe-β-CDx complex 
was released from two TMe-β-CDx cavities and intercalated 
into DNA under acidic conditions. A cationic 1 born by 
protonation of the 4-pyridyl moiety causes destabilisation of 
the 1•TMe-β-CDx complex and stabilisation of the 
intercalation of 1 into anionic DNA, as observed previously 
for TMPyP. However, in contrast to this previous study, the 
DNA-intercalated 1 returned to the TMe-β-CDx cavities 
under neutral pH conditions. The release of 1 from DNA 
occurred because of the stabilisation of the 1•TMe-β-CDx 
complex and destabilisation of 1 intercalated into anionic 
DNA. The reaction was repeatedly reversible by changing 
the pH. 
Supporting Information Summary 
The supporting information includes experimental details 
regarding to the materials, preparation of the mixture of the 
1•TMe-β-CDx complex with DNA, and measurements. The 
the inhibition of the rotation of the pyridyl moieties in 1 by 
complexation of TMe-β-CDx, Hill plots, complete NMR 
spectra of Figure 3, UV-vis absorption spectra of the 1•TMe-
β-CDx complex in buffer solution, and CD spectra of the 
mixture of the 1•TMe-β-CDx complex with DNA and DNA 
alone can also be found in the supporting information. 
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5,10,15,20-Tetra(4-pyridyl)porphyrin (1) in the 1•TMe-β-CDx complex was released from two TMe-β-CDx cavities and intercalated 
into DNA under acidic conditions. A cationic 1 born by protonation of the 4-pyridyl moiety causes destabilisation of the 1•TMe-β-CDx 
complex and stabilisation of the intercalation of 1 into anionic DNA. In contrast, the DNA-intercalated 1 returned to the TMe-β-CDx 
cavities by the deprotonation of 1 under neutral pH conditions. The reaction was repeatedly reversible by changing the pH. 
